Skip to main content
Air Liquide
Air Liquide worldwide
Please select

Engineering & Construction


Large projects



Connected solutions for effective
Obstructive Sleep Apnea treatment

Paul is a 45-year-old active man. He seems healthy but he is suffering from Obstructive Sleep Apnea (OSA). Follow his year-long story and discover how treatment and our support program have improved his health and his quality of life.

Day 1

The disease diagnosis

A year ago, Paul’s doctor diagnosed him with Obstructive Sleep Apnea. The diagnosis is realized during sleep, with a respiratory polygraphy or polysomnography exam.

“I was tired and anxious all the time. I was affected with frequent headaches. I also felt a sense of loneliness: no one understood what I was going through.”

Paul's nights were restless.

The muscles in his throat would relax, causing the airway to be obstructed and thus preventing Paul from breathing. Some nights, Paul would suffer from more than 30 episodes of apnea an hour.

1 to 6% Obstructive Sleep Apnea affects
1 to 6% of the world’s adult population.(1)

The risks associated with untreated Obstructive Sleep Apnea are: hypertension, cardiac arrhythmia, stroke, diabetes, obesity, drowsiness, with 7-fold risk of traffic accidents, impact on one’s family life, impact on one’s work capacity.(2)

(1) The World Health Organization. Chronic respiratory diseases consulted on 02/13/2015 (2) British Lung Foundation, consulted on 02/13/2105

Day 2

Treatment initiation

Once diagnosed, physician prescribed to Paul a Continuous Positive Airway Pressure (CPAP) treatment.

At the start of the treatment, Paul benefited from the support of a specialized technician of Air Liquide Healthcare, Marc, who came to his home to set up the device.

He explained to Paul the treatment, starting for better understanding the illness and the risk for not being treated. He gave him some advice about how to operate and keep good care of the equipment. He stressed the importance to be compliant in order to have an efficient treatment.

The CPAP device

Used at the patient’s home during the night, the CPAP device is small, light and quiet. It makes sure Paul’s airways stay open, thus preventing any apnea episodes, by providing him with a steady flow of air through a mask.

“It felt good to talk to someone who knows about my disease and its treatment. I was reassured hearing about how other patients have noted clear improvements had been made with such treatment.”

Day 5

Compliance challenge

One in two patients is tempted to give up the treatment during the first month.
Can Respir J Vol 15 No 7 October 2008

To monitor compliance to treatment, a remote system called


can be added to the medical equipment (CPAP machine) from the first day of patient’s treatment.

NOWAPITM enables to monitor that the treatment program is operating smoothly on a daily basis, to analyze and to reinforce patient commitment to the treatment by supporting him with follow-up program.

It sends the patient’s data to a professional of Air Liquide Healthcare who synthesizes these data to send to the doctor. Then, doctor with the assistance of technician can adapt the treatment according to the data to meet Paul’s needs.
Nowapitm: Manufactured by Air Liquide Medical Systems S.A. According to the European regulation, this health product is a medical device class IIa, and is CE marked. CE0459. March 24th 2015.

Day 32

Support program

Through specific calls with our dedicated nurses and technicians, we organize meetings and motivational interviews that aim to explain and make sure the patient has understood why it is so important to stick to the treatment, which can only improve his quality of life.

« We helped Paul feel supported during the crucial starting phase, as well as when he had difficulty adhering to his treatment. This ongoing connection with the patient and the doctor helps maximize the effectiveness of the treatment and improve Paul’s well-being. »

Day 180

The doctor's follow-up

Through remote monitoring, Paul’s doctor receives since the treatment’s initiation all of the data needed to follow and adjust the treatment to meet Paul’s specific needs.

The results achieved with Air Liquide Healthcare solutions are:

  • Improved treatment adherence that could result lowered risks of cardiovascular and other health problems
  • Reduced sleepiness, lower traffic accidents, while containing health costs

This is a win-win situation for all involved parties.

Day 365

To sum up

After one year of treatment, Paul says he feels healthier. His drowsiness is reduced considerably.

”It’s been a major improvement to my quality of life.”

Air Liquide Healthcare teams will regularly monitor Paul during his treatment.

Daily report

Number of hours using the CPAP treatment
Apnea Hypopnea Index (AHI)
Comfort and quality of life
Treatment compliance level
AHI: A measurement used to indicate the severity of sleep apnea represented by the number of apnea and hypopnea per hour of sleep. Hypopnea: disorder which involves episodes of overly shallow breathing or an abnormally low respiratory rate.